<The stock market can be notoriously inefficient, but the market for buying and selling drugs and drug companies is generally quite efficient.>
Are you saying that GTCB management would not accept a takeover offer that gets shareholders $0.80 a share if the current share price is $0.40 a share?
"The stock market can be notoriously inefficient, but the market for buying and selling drugs and drug companies is generally quite efficient."
Efficient Market: A market where prices reflect all available information.
I guess the definition is clear but the question is: what is really the "efficient" market cap value of GTCB? Is it the $40 million, where we are currently, or is it the $400 million that many of us were hoping for?